Effectiveness of Thyme in the Management of Clinical Symptoms in Patients with Irritable Bowel Syndrome

Launched by SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES · Sep 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether taking a thyme supplement can help improve symptoms and quality of life for people with Irritable Bowel Syndrome (IBS) when combined with a low FODMAP diet. FODMAPs are certain types of carbohydrates that can trigger digestive issues in some individuals. The researchers want to find out if thyme can make this diet more effective in reducing IBS symptoms, such as stomach pain and bloating, and if it can enhance overall well-being.

To be eligible to participate, you need to be between the ages of 18 and 65 and have a diagnosis of IBS. Participants will take either the thyme supplement or a placebo (a non-active pill) along with following the low FODMAP diet for 8 weeks. They'll also keep track of their food intake for three days at two points during the study and visit the clinic at the start and end for check-ups. This trial is not yet recruiting participants, but it's an exciting opportunity for those looking for potential new ways to manage their IBS symptoms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ages 18-65;
• • Patients with irritable bowel syndrome;
• • Body Mass Index in the range of 18-25 kg/m2
• Exclusion Criteria:
• • Any organic intestinal disease;
• • Medical history of chronic gastrointestinal and colorectal disease;
• • Any major bowel surgery;
• • Medical history of liver and kidney disorders;
• • Regular use of laxative, anti-diarrhea and anti inflammatory medications.